UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

L-Type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs)

International journal of pharmaceutics, 2019-11, Vol.571, p.118714, Article 118714

2019

Volltextzugriff (PDF)

Prodrugs - an efficient way to breach delivery and targeting barriers

Current topics in medicinal chemistry, 2011-09, Vol.11 (18), p.2265-2287

2011

Volltextzugriff (PDF)

Is Metformin a Perfect Drug? Updates in Pharmacokinetics and Pharmacodynamics

Current pharmaceutical design, 2017-01, Vol.23 (17)

2017

Volltextzugriff (PDF)

A Selective and Slowly Reversible Inhibitor of l‑Type Amino Acid Transporter 1 (LAT1) Potentiates Antiproliferative Drug Efficacy in Cancer Cells

Journal of medicinal chemistry, 2016-06, Vol.59 (12), p.5740-5751

2016

Volltextzugriff (PDF)

Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis

Apoptosis (London), 2020-06, Vol.25 (5-6), p.426-440

2020

Volltextzugriff (PDF)

Prodrugs--from serendipity to rational design

Pharmacological reviews, 2011-09, Vol.63 (3), p.750-771

2011

Volltextzugriff (PDF)

Astrocyte-Targeted Transporter-Utilizing Derivatives of Ferulic Acid Can Have Multifunctional Effects Ameliorating Inflammation and Oxidative Stress in the Brain

Oxidative medicine and cellular longevity, 2019, Vol.2019 (2019), p.1-13

2019

Volltextzugriff (PDF)

Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs)

Pharmaceutics, 2022-06, Vol.14 (6), p.1234

2022

Volltextzugriff (PDF)

Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and rats

International journal of pharmaceutics, 2021-03, Vol.596, p.120300, Article 120300

2021

Volltextzugriff (PDF)

Mechanistic Study on the Use of the l‑Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets

Molecular pharmaceutics, 2019-07, Vol.16 (7), p.3261-3274

2019

Volltextzugriff (PDF)

Improving drug delivery to the brain: the prodrug approach

Expert opinion on drug delivery, 2024-05, Vol.21 (5), p.683-693

Huttunen, Kristiina M

2024

Volltextzugriff (PDF)

Systemic and Brain Pharmacokinetics of Perforin Inhibitor Prodrugs

Molecular pharmaceutics, 2016-07, Vol.13 (7), p.2484-2491

2016

Volltextzugriff (PDF)

Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho -Carboranylmethyl-Bearing Glucoconjugates

Molecular pharmaceutics, 2021-01, Vol.18 (1), p.285-304

2021

Volltextzugriff (PDF)

Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation

Journal of enzyme inhibition and medicinal chemistry, 2018-01, Vol.33 (1), p.1309-1322

2018

Volltextzugriff (PDF)

Metformin – a Future Therapy for Neurodegenerative Diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla

Pharmaceutical research, 2017-12, Vol.34 (12), p.2614-2627

2017

Volltextzugriff (PDF)

Novel Sulfonamide-Based Analogs of Metformin Exert Promising Anti-Coagulant Effects without Compromising Glucose-Lowering Activity

Pharmaceuticals (Basel, Switzerland), 2020-10, Vol.13 (10), p.323

2020

Volltextzugriff (PDF)

Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure

Neurochemical research, 2016-10, Vol.41 (10), p.2797-2809

2016

Volltextzugriff (PDF)

Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain

Frontiers in pharmacology, 2022-10, Vol.13, p.1034964-1034964

2022

Volltextzugriff (PDF)

L-Type Amino Acid Transporter 1-Utilizing Prodrugs of Ketoprofen Can Efficiently Reduce Brain Prostaglandin Levels

Pharmaceutics, 2020-04, Vol.12 (4), p.344

2020

Volltextzugriff (PDF)

Targeted efflux transporter inhibitors – A solution to improve poor cellular accumulation of anti-cancer agents

International journal of pharmaceutics, 2018-10, Vol.550 (1-2), p.278-289

2018

Volltextzugriff (PDF)

L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery

European journal of pharmaceutical sciences, 2019-03, Vol.129, p.99-109

2019

Volltextzugriff (PDF)

Metformin derivatives – Researchers’ friends or foes?

Biochemical pharmacology, 2023-09, Vol.215, p.115743-115743, Article 115743

2023

Volltextzugriff (PDF)

Amino acids as promoieties in prodrug design and development

Advanced drug delivery reviews, 2013-10, Vol.65 (10), p.1370-1385

2013

Volltextzugriff (PDF)

Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways

Inflammopharmacology, 2021-08, Vol.29 (4), p.965-974

2021

Volltextzugriff (PDF)

Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives

Neurochemistry international, 2024-07, Vol.177, p.105771, Article 105771

2024

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

ThemaChemistry

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

L-Type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs)

Prodrugs - an efficient way to breach delivery and targeting barriers

Is Metformin a Perfect Drug? Updates in Pharmacokinetics and Pharmacodynamics

A Selective and Slowly Reversible Inhibitor of l‑Type Amino Acid Transporter 1 (LAT1) Potentiates Antiproliferative Drug Efficacy in Cancer Cells

Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis

Prodrugs--from serendipity to rational design

Astrocyte-Targeted Transporter-Utilizing Derivatives of Ferulic Acid Can Have Multifunctional Effects Ameliorating Inflammation and Oxidative Stress in the Brain

Increased/Targeted Brain (Pro)Drug Delivery via Utilization of Solute Carriers (SLCs)

Species differences in the intra-brain distribution of an L-type amino acid transporter 1 (LAT1) -utilizing compound between mice and rats

Mechanistic Study on the Use of the l‑Type Amino Acid Transporter 1 for Brain Intracellular Delivery of Ketoprofen via Prodrug: A Novel Approach Supporting the Development of Prodrugs for Intracellular Targets

Improving drug delivery to the brain: the prodrug approach

Systemic and Brain Pharmacokinetics of Perforin Inhibitor Prodrugs

Exploring the Biochemical Foundations of a Successful GLUT1-Targeting Strategy to BNCT: Chemical Synthesis and In Vitro Evaluation of the Entire Positional Isomer Library of ortho -Carboranylmethyl-Bearing Glucoconjugates

Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation

Metformin – a Future Therapy for Neurodegenerative Diseases: Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla

Novel Sulfonamide-Based Analogs of Metformin Exert Promising Anti-Coagulant Effects without Compromising Glucose-Lowering Activity

Amino Acid Promoieties Alter Valproic Acid Pharmacokinetics and Enable Extended Brain Exposure

Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain

L-Type Amino Acid Transporter 1-Utilizing Prodrugs of Ketoprofen Can Efficiently Reduce Brain Prostaglandin Levels

Targeted efflux transporter inhibitors – A solution to improve poor cellular accumulation of anti-cancer agents

L-type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery

Metformin derivatives – Researchers’ friends or foes?

Amino acids as promoieties in prodrug design and development

Orchestrated modulation of rheumatoid arthritis via crosstalking intracellular signaling pathways

Amino acid transporters in neurological disorders and neuroprotective effects of cysteine derivatives

Aktive Filter

Suchergebnisse filtern